AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Market Cap $82.91M
!
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Last update - 16.10pm 30/07/2026 (20 minute delay)
?
| Day | ||||||||
|---|---|---|---|---|---|---|---|---|
| Open | 55.0¢ | Day High | 59.0¢ | Day Low | 55.0¢ | |||
| Daily Volume | 119095 | |||||||
| Bids | Sellers | |||||
|---|---|---|---|---|---|---|
| Number | Price | Volume | Number | Price | Volume | |
| 0 | 53.0¢ | 78515 | 0 | 59.5¢ | 8444 | |
Directors & Senior Management
| Mr. Angus William Murnaghan | Independent Non-Executive Director |
| Mr. David James Rich | Head of Corporate Development |
| Mr. David Patrick Alexander Singleton | Independent Non-Executive Director |
| Mr. John Bradley Miocevich | Non-Executive Chairman |
| Mr. Mark David Miocevich | MD & Director |
| Mr. Peter Patrick Torre | Independent Non-Executive Director |
| Mr. Tinotenda Alfred Kapfumo | CFO & Company Secretary |
| Mr. Trevor Raman | Chief Executive Officer |
Data source: ADVFN
